Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Germacrone protects against oxygen-glucose deprivation/reperfusion injury by inhibiting autophagy processes in PC12 cells

BMC Complementary Medicine and Therapies volume 20, Article number: 77 (2020) Cite this article

Abstract

Background

Germacrone is an anti-inflammatory ingredient in the Chinese medicine zedoary turmeric. The purpose of this study was to explore the protective mechanism of germacrone against PC12 cells injury caused by oxygen-glucose deprivation/reperfusion (OGD/R).

Methods

OGD/R injury model of PC12 cells was established by using OGD/R (2 h/24 h). The cell viability was assessed by MTT assay and LDH release. The ultrastructure of cells was observed by transmission electron microscopy (TEM). The expression of autophagy related proteins in cells was determined by Western Blot.

Results

The results of ultrastructural observation showed that PC12 cells damaged by OGD/R showed typical autophagy characteristics. In addition, OGD/R observably up-regulated the expression of autophagy related proteins: the class III type phosphoinositide 3-kinase (PI3K III), light chain 3(LC3), and Beclin-1 in PC12 cells, and inhibited the expression of the class I type phosphoinositide 3-kinase (PI3K I), Protein kinase B (Akt), the mammalian target of rapamycin (mTOR), and B-cell lymphoma 2(Bcl-2) proteins. Furthermore, germacrone increased the cell viability of OGD/R-damaged PC12 cells by down-regulating the expression of LC3 protein in cells in a concentration-dependent manner. More importantly, germacrone significantly inhibited the expression of PI3K III, LC3, and Beclin-1 in OGD/R-injured PC12 cells, and up-regulated the expressionof PI3K I, Akt, mTOR, and Bcl-2 proteins in cells, and this inhibited or up-regulated effect was reversed by PI3K I inhibitor (ZSTK474).

Conclusion

The above results indicated that germacrone could inhibit the autophagy effect in OGD/R injury model of PC12 cells, the mechanism of inhibition was regulated by PI3K III/Beclin-1/Bcl-2 and PI3K I/Akt/mTOR pathways, thereby improving the cell viability of PC12 cells and playing a neuroprotective role, which provided a new drug for the treatment of OGD/R.

Peer Review reports

Background

According to the regulation of autophagy related genes, autophagy involves the encapsulation of damaged organelles and proteins and then degradation of its contents by lysosomes, so as to form auto-phagosome with double-layer membrane structure and complete the turnover and metabolism of intracellular substances [1,2,3]. Cerebral hypoxic ischemia/reperfusion (I/R) injury can activate the autophagy effect of neurons [4]. Moderate autophagy induced by mild hypoxia can enhance the ability of nerve cells to resist changes in the external environment, thus improving the survival rate of cells [5]. However, excessive activation of autophagy caused by severe hypoxia can lead to injury and apoptosis of nerve cells [6].

Microtubule-associated protein 1 light chain 3(LC3) exists in two forms: LC3-I and LC3-II. when autophagy is activated, free LC3-I in the cytoplasm can combine with the phosphatidyl ethanolamine (PE) to form the LC3-II [7]. LC3-II of 14 kD is located on the auto-phagosome membrane, and its content is proportional to the number of auto-phagosome vesicles, so LC3-II is one of the marker proteins of auto-phagosome formation [8]. LC3-II/LC3-I ratio is usually adopted to reflect the number of auto-phagosomes and the level of autophagy in cells [9]. Studies have found that PI3K I/Akt/mTOR and PI3K III/Beclin-1/Bcl-2 are important signaling pathways involved in cell autophagy [10, 11]. The activation of PI3K I/Akt/mTOR signaling pathway inhibits autophagy effect in various cells, and activated PI3K I can up-regulate the expression of Akt, and activate the downstream mTOR protein phosphorylation [12]. The mTOR is an important factor related to autophagy, and its activation can effectively block the activation of autophagy effect [13]. In PI3K III/Beclin-1/Bcl-2 signaling pathway, Beclin-1 is a specific autophagy gene, and Beclin-1 protein can form a complex with PI3K III to induce autophagy related proteins to locate in the auto-phagosome membrane, thus promoting the formation of auto-phagosome [14].

Germacrone is one of the active components in zedoary turmeric extract, which has anti-inflammatory, antioxidant and antiviral activities [15, 16]. Feng et al. reported that in the antiviral test in vitro, germacrone showed high anti-porcine reproductive respiratory syndrome virus (PRRSV) infection activity by inhibiting the replication process of PRRSV [17]. Recent studies have found that germacrone has a significant anti-cancer effect, can inhibit the progress of colorectal cancer, liver cancer, breast cancer, lung cancer and other cancers, and has the characteristics of high efficiency and low toxicity [18,19,20]. Lim et al. found that germacrone inhibited breast cancer progression by inhibiting estrogen receptor α and synergizing with other anti-tumor drugs 5- fluorouracil and methotrexate [21]. However, there are relatively few studies on the neuroprotective effects of germacrone. Previous work found that microglial activation had crucial effects on neuroprotection and neuroinflammatory response, but its over-activation was neurotoxic. For instance, the activation of peroxisome proliferator-activated receptor gamma pathway could induce M2 phenotype of microglia (alternative activation), and promote proliferation and differentiation of neural precursor cells; M2 microglia could reduce inflammatory response with releasing anti-inflammatory cytokines (like IL-10, IL-4 and TGF-β) and then promote neurogenesis and repair [22]. In addition, the anti-inflammatory agents could modulate microglial activation and then provide neuroprotection [23]. Wu et al. investigated the neuroprotective effects of germacrone in rats of transient middle cerebral artery occlusion/reperfusion injury, and showed germacrone could attenuate that injuries [24]. As a result, we speculated that germacrone might play an important role in neuroprotection. In this study, the oxygen-glucose deprivation/reperfusion (OGD/R) model of PC12 cells was established to simulate the hypoxic I/R injury of nerve cells in vitro, in order to explore the protective mechanism of natural compound germacrone on autophagy induction during OGD/R injury of PC12 cells, which would provide a certain theoretical basis for further development and utilization of germacrone.

Methods

Materials

Germacrone with purity greater than 98% (molecular weight: 218.34) was purchased from Nanjing puyi biotechnology co., LTD. (Nanjing, China), and its chemical structure was shown in Fig. 1.

Fig. 1
figure 1

Chemical structure diagram of germacrone (C15H22O)

Full size image

Cell culture

PC12 neurons (rat adrenal pheochromocytoma cells) were obtained from the key laboratory of neurobiology, Shanghai institute of life sciences, Chinese academy of sciences, the number in American Type Culture Collection (ATCC) is CRL-1721. PC12 neurons were cultured using RPMI 1640 medium (Gibco, Paisley, Scotland) containing 7.5% horse serum and 10% Fetal Bovine Serum (Gibco) in an incubator at 37 °C with 5% CO2.

Establishment of PC12 cell OGD/R model

The improved OGD/R method was used to simulate reperfusion injury (I/R) in vitro, and PC12 cell OGD/R model in vitro was established [25]. Briefly, the culture medium (RPMI 1640 medium) was removed and PC12 cells (1 × 105 cells) were washed twice using RPMI 1640 medium (without glucose). PC12 cells were transferred to 37 °C, N2/CO2 (95%/5%) in a hypoxic incubator chamber (Thermo, USA) for 10 min to reduce the oxygen content of the cells below 1%. Then, RPMI 1640 culture medium (without glucose) was added to the cells for 2 h in the hypoxic incubator chamber, namely OGD phase. Next, cells were cultured in RPMI 1640 medium containing 7.5% horse serum and 10% FBS at air/CO2 (95%/5%), namely R phase. The control cells were not treated with OGD/R.

Experimental grouping

Firstly, PC12 cells were divided into control group and OGD/R groups, and the reperfusion time of OGD/R groups was 0, 3, 6, 12, 24 and 48 h, respectively, so as to determine the optimal reperfusion time of OGD/R model. Next, PC12 cells were treated with 5–80 μM germacrone for 2 h after OGD/R, and 10 μM nimodipine (Bayer healthcare Co., Ltd., Leverkusen, Germany) as a positive control group, to determine the optimal treatment concentration for germacrone. PC12 cells were then treated 30 min before OGD/R with 10 mM PI3K III inhibitor 3-MA (Sigma) and 1 μM PI3K I inhibitor Selleck (ZSTK474) to determine the effect of germacrone on autophagy in PC12 cells. Nimodipine was dissolved in RPMI 1640 medium. The germacrone, 3-MA and ZSTK474 were dissolved in DMSO (Sigma), and the final concentration of DMSO was less than 0.1%.

Observation of the ultrastructure of cells by TEM

TEM (Hitachi-600, Japan) was used to observe the ultrastructural changes of PC12 cells, so as to evaluate the formation of auto-phagosomes in cells. Simply put, PC12 cells were treated accordingly and collected. Cells were fixed with 2.5% glutaraldehyde and incubated with 1% OsO4. Next, cells were dehydrated with gradient ethanol and embedded with Epon 812. Cells were then stained with citric acid and uranium acetate and photographed using TEM.

Cell viability assay

MTT (Sigma) and LDH kit (Nanjing jiancheng institute of biological engineering) were used to determine the cell viability of PC12 cells. MTT assay was performed as described in the literature [26]. LDH release in cell supernatant was determined with LDH kit, and the specific steps were strictly in accordance with the instructions of the kit.

Western blot analysis

Western blot analysis was performed as described in the literature [27]. In brief, the total proteins in cells were extracted using cell lysate, and were quantified. The extracted proteins were separated by 10–15% SDS-PAGE and transferred to cellulose acetate membrane. The 5% skim milk powder solution was used to close the membrane for 2 h, then the primary antibody was used to incubate the membrane at 4 °C overnight. The goat IgG with HRP conjugate (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was incubated at room temperature for 1 h. The protein band was then colored and the grayscale value of the protein band was analyzed using ImageJ software. The β-actin (1, 5000, Beijing zhongshan jinqiao biotechnology co., LTD., Beijing, China) was used as an internal control. Among them, mTOR, Akt, PI3K I, Bcl-2, PI3K III, Beclin-1 and LC3 were obtained from Abcam (Cambridge, Massachusetts, USA) with a dilution ratio of 1: 1000.

Statistical analysis

All data were expressed as mean standard ± deviation (SD). One-way ANOVA and post-test LSD were used for significance analysis, and P < 0.05 indicated a significant difference.

Results

Effect of OGD/R on cell viability and autophagy in PC12 cells

The cell viability of PC12 cells was determined by MTT assay and toxicity test kit. MTT results showed that with the extension of reperfusion time, the cell viability showed a declining trend and reached the lowest value at 24 h after reperfusion (Fig. 2A, P < 0.01). Meanwhile, LDH results showed that with the extension of reperfusion time, the release of LDH in PC12 cells showed an increasing trend, and the highest value was reached at 24 h after reperfusion (Fig. 2B, P < 0.01). In addition, we used TEM to observe the ultrastructure of PC12 cells. The results found that the internal structure of cells in the control group was normal, while cells in the OGD/R 0-h group began to show vesicles with auto-phagosome characteristics, indicating that OGD/R had caused the activation of autophagy effect in PC12 cells (Fig. 2C). At the same time, the number of vesicles was the highest in the OGD/R 24 h group, and the typical characteristics of apoptosis and necrosis were observed in cells (Fig. 2C), suggesting that the autophagy effect of PC12 cells induced by OGD/R 24 h was the most significant.

Fig. 2
figure 2

Effect of OGD/R on cell viability and autophagy in PC12 cells (A) Determination of the cell viability of PC12 cells without OGD/R injury and after OGD/R (0, 3, 6, 12, 24 and 48 h) injury by MTT assay. The control group without OGD/R injury. (B) Determination of the LDH release of PC12 cells after OGD/R by kit assay. (C) Observation of the ultrastructural changes of PC12 cells after OGD/R 0 h(b), 3 h(c), 6 h(d), 12 h(e), 24 h(f) and 48 h(g) injury by TEM (× 20,000). Note: n = 6; #P < 0.05, ##P < 0.01, vs control group (a)

Full size image

Effect of OGD/R on autophagy related protein expressions in PC12 cells

LC3 and Beclin-1 are typical markers of autophagy activation [28]. The effect of OGD/R on the expression of LC3 and Beclin-1 in PC12 cells was first determined by Western Blot. The results showed that compared with the control group, the expression of LC3-II/LC3-I and Beclin-1 in cells of the OGD/R 0-h group was remarkably up-regulated (P < 0.05), and reached the maximum at 24 h of OGD/R (Fig. 3a, b and g, P < 0.01). In addition, we also determined the effect of OGD/R on two autophagy related signaling pathways, PI3K I/Akt/mTOR and PI3K III/Beclin-1/Bcl-2, in PC12 cells. The results found that compared with the control group, OGD/R observably inhibited PI3K I and Akt protein expressions in cells and reached the lowest level at 12 h after OGD/R (Fig. 3a, c and d, P < 0.01). Meanwhile, the protein expression of mTOR in cells with OGD/R for 3 h began to be significantly down-regulated (P < 0.05), and reached the minimum at 24 h after OGD/R (Fig. 3a and e, P < 0.01). Furthermore, OGD/R remarkably upregulated the protein expression of PI3K III in cells and reached a maximum at 12 h after OGD/R (Fig. 3a and f, P < 0.01). Simultaneously, the protein expression of Bcl-2 began to be markedly down-regulated in the OGD/R 3 h group (P < 0.05), and reached the minimum at 24 h after OGD/R (Fig. 3a and h, P < 0.01). Based on the above experimental results, 24 h of OGD/R was selected for the following experimental research.

Fig. 3
figure 3

Effect of OGD/R on autophagy related protein expressions in PC12 cells a Detection of the protein expressions of LC3, Beclin-1, PI3K III, Bcl-2, PI3K I, p-Akt and p-mTOR in PC12 cells by Western Blot. b-h Quantitative analysis of the gray value of each protein band. Note: n = 3; #P < 0.05, ##P < 0.01, vs control group. p-Class I PI3K: PI3K I protein; p-Akt: Akt protein; p-mTOR: mTOR protein; Class III PI3K: PI3K III protein

Full size image

Effects of different concentrations of germacrone on PC12 cell viability

First, No OGR/R treated PC12 cells were treated with germacrone at 1.25–80 μM for 24 h, and the activity of PC12 cells was determined by MTT assay. The results showed that, compared with the control group (not treated with germacrone or OGR/R injury), germacrone at different concentrations had no significant effect on the cell viability of PC12 cells (Fig. 4a, P > 0.05), indicating that germacrone had no toxic effect on PC12 cells. In addition, we also determined the effect of different concentrations of germacrone (1.25–80 μM) on the activity of PC12 cells after the OGD/R 24 h injury. The results found that the cell viability of PC12 cells in the OGD/R 24 h group was remarkably lower than that in the control group (P < 0.01), while that in germacrone groups (10–80 μM) were significantly higher than that in the OGD/R 24 h group (Fig. 4b, P < 0.05, P < 0.01). The protective effect of 80 μM germacrone treatment group was similar to that of the positive control drug nimodipine. The above results showed that germacrone (10–80 μM) could observably up-regulate the cell viability of PC12 cells after OGD/R 24 h injury. In subsequent experiments, PC12 cells were treated with 20, 40, and 80 μM germacrone.

Fig. 4
figure 4

Effect of different concentrations of germacrone on PC12 cell viability a Detection of the effect of 1.25–80 μM germacrone on PC12 cells viability by MTT assay. b Detection of the effect of germacrone on PC12 cells viability after OGD/R injury by MTT assay. Note: n = 6; ##P < 0.01, vs control group; *P < 0.05, **P < 0.01, vs OGD/R group

Full size image

Germacrone alleviated OGD/R-induced PC12 cell injury by inhibiting autophagy

First, PC12 cells were treated with 10 mM 3-MA or 20–80 μM germacrone to investigate the effect of germacrone on autophagy and cell viability in PC12 cells after OGD/R 24 h injury. LDH assay results showed that the LDH release of PC12 cells treated with 3-MA and germacrone was observably lower than that of OGD/R 24 h group (Fig. 5A, P < 0.01). Furthermore, MTT assay showed that the cell viability of PC12 cells treated with 3-MA and germacrone was remarkably higher than that of OGD/R group (Fig. 5B, P < 0.05, P < 0.01). In addition, Western Blot results showed that the expression of LC3-II/LC3-I in cells of the 3-MA and germacrone treatment groups were markedly lower than that of the OGD/R 24 h group (Fig. 5C, P < 0.05, P < 0.01), which suggested that 3-MA or germacrone effectively blocked the autophagy activation of PC12 cells induced by OGD/R 24 h injury. Besides, in order to verity the effect of germacrone in PC12 cells after OGD/R 24 h injury, we observed the ultrastructural changes in each group by TME. The results showed OGD/R induced some auto-phagosome in cells, while the introduction of 3-MA or germacrone inhibited the formation of auto-phagosome vesicles. Meanwhile, the number of vesicles tended to decrease after treated with 20, 40 and 80 μM germacrone, and the group treated with 80 μM germacrone showed similar characteristics with the 3-MA and control group (Fig. 5D).

Fig. 5
figure 5

Germacrone alleviated OGD/R-induced PC12 cells injury by inhibiting autophagy (A) Detection of the LDH release in each group by kit assay (n = 6). (B) Detection of the cell viability of each group by MTT assay (n = 6). (C) Detection of the expression of LC3 in cells of each group by Western Blot (n = 3). (D) Observation of the ultrastructural of PC12 cells without OGD/R injury(a) and after OGD/R 24 h injury(b), as well as the ultrastructural of PC12 cells treated with 20 μM (c), 40 μM (d), 80 μM(e) of germacrone and 3-MA(f) after OGD/R 24 h injury by TEM (× 20,000). Note: ##P < 0.01, vs control group; *P < 0.05, **P < 0.01, vs OGD/R group

Full size image

The molecular mechanism of germacrone blocked OGD/R-induced autophagy in PC12 cells

In order to explore the mechanism of germacrone blocking autophagy in PC12 cells induced by OGD/R 24 h injury, the expression of autophagy related proteins in PC12 cells was determined by Western Blot. The results showed that compared with the OGD/R 24 h group, the expression of LC3-II/LC3-I, PI3K III and Beclin-1 in the germacrone and/or 3-MA treatment groups was markedly down-regulated (Fig. 6A, B, F and G, P < 0.01), while the expression of Bcl-2 was significantly up-regulated (Fig. 6A, H, P < 0.01). In addition, compared with the OGD/R 24 h group, the expression of PI3K I, Akt and mTOR in the germacrone treatment groups was significantly increased (P < 0.01), and germacrone also alleviated the inhibitory effect of ZSTK474 on the expression of these proteins (Fig. 6A, C, D and E, P < 0.01). The above results suggested that germacrone blocked the activation of OGD/R 24 h induced autophagy in PC12 cells by regulating the PI3K III/Beclin-1/Bcl-2 and PI3K I/Akt/mTOR pathways.

Fig. 6
figure 6

The molecular mechanism of germacrone blocked OGD/R-induced autophagy in PC12 cells (A) Compare the effect of treatment with PI3K III inhibitor (3-MA)(a) and PI3K I inhibitor (ZSTK474)(b). Detection of the protein expression of LC3, Beclin-1, PI3K III, Bcl-2, PI3K I, p-Akt and p-mTOR in PC12 cells by Western Blot. (B-H) Quantitative analysis of the gray value of each protein band. Note: n = 3; ##P < 0.01, vs control group; *P < 0.05, **P < 0.01, vs OGD/R group. p-Class I PI3K: PI3K I protein; p-Akt: Akt protein; p-mTOR: mTOR protein; Class III PI3K: PI3K III protein

Full size image

Discussion

PC12 cell lines, derived from rat adrenal medulla pheochromocytoma, can secrete catecholamine transmitters and have sympathetic neuron characteristics, so they have been widely used in vitro to study of neuron injury mechanism [29, 30]. Studies have found that severe cerebral hypoxic I/R injury can induce autophagic death of neurons [31, 32]. At present, OGD/R model can simulate cerebral ischemia and hypoxia in vivo, which is a classic and mature model for in vitro ischemia and hypoxia research [33]. In this method, the concentration of CO2 and O2 in the incubator was precisely controlled by direct instillation of N2, and the glucose in the cell culture medium was deprived at the same time, so as to create a hypoxic and hypoxic environment for cultured cells and simulate the situation of cerebral ischemia and hypoxia in vivo [34]. MTT assay is a classical method to detect cell survival and growth, and LDH release can reflect the degree of cell necrosis [35].

LC3-II is one of the marker proteins for the formation of auto-phagosomes, and the ratio of LC3-II/LC3-I is usually used to reflect the number of auto-phagosomes and the level of autophagy in cells [36]. Mo et al. found that after OGD/R injury, the expression of autophagy related protein LC3-II in PC12 cells, was markedly increased, and the cell survival rate was significantly reduced [37]. In the present study, it was found that the expression of LC3-II/LC3-I in cells treated with OGD/R was remarkably up-regulated and reached the maximum at 24 h after OGD/R treatment, suggesting that OGD/R might activate the autophagy effect in PC12 cells. It has been found that PI3K I/Akt/mTOR and PI3K III/Beclin-1/Bcl-2 are important signaling pathways involved in cell autophagy [38, 39]. This study found that OGD/R could observably inhibit the expression of PI3K I, Akt and mTOR, which indicated that OGD/R could repress the PI3K I/Akt/mTOR pathway to promote the autophagy effect of PC12 cells. Meanwhile, OGD/R could markedly increase the protein expression of PI3K III and Beclin1, and down-regulate the expression of Bcl-2, which suggested that OGD/R could induce the autophagy effect of PC12 cells through the activation of PI3K III/Beclin-1/Bcl-2 pathway. Based on the above experimental results, 24 h of OGD/R was selected for the following experimental research.

Germacrone has anti-inflammatory, antioxidant, antiviral and anti-tumor and other physiological activities [40,41,42]. The role of germacrone has attracted our attention in the OGD/R-damaged PC12 cells. In this study, the OGD/R model of PC12 cells was established to explore the protective mechanism of germacrone on the induction of autophagy during OGD/R 24 h injury. The results showed that germacrone (10–80 μM) could remarkably up-regulate the cell viability of PC12 cells after OGD/R injury, and 20, 40 and 80 μM germacrone were selected to treat PC12 cells in follow-up experiments. Classic autophagy upstream inhibitor 3-MA can inhibit the activity of PI3K III type, thus inhibiting the formation of autophagy body [43]. The results of this study showed that 3-MA or 80 μM germacrone effectively inhibited the expression of autophagy related proteins in OGD/R-induced PC12 cells, thereby improving the cell viability of PC12 cells after OGD/R injury. In addition, this study also found that OGD/R and PI3K I inhibitor ZSTK474 observably inhibited the PI3K I/Akt/mTOR pathway, and 80 μM germacrone remarkably alleviated the inhibitory effect. Chang et al. found that ganoderic acid A could alleviate the autophagy effect of rat neural stem cells activated by hypoxia injury by activating the PI3K I/AKT/mTOR pathway [44]. Huang et al. reported that the combination of Ginsenoside Rg1 and Astragaloside IV inhibited OGD/R-induced autophagy in PC12 cells by regulating PI3K III/Beclin-1/Bcl-2 and PI3K I/Akt/mTOR pathways [45]. Therefore, the results of this study suggested that germacrone inhibited the activation of OGD/R-induced autophagy in PC12 cells by blocking the PI3K III/Beclin-1/Bcl-2 pathway and activating the PI3K I/Akt/mTOR pathway.

In addition, in recent studies, the main limitation of how to deal with autophagy due to nerve injury is the lack of vivo experiments. In recently published work, it has been reported that modulation of microglial activation with anti-inflammatory agents can provide neuroprotection [22, 23]. Since germacrone contains anti-inflammatory ingredients, Therefore, dose germacrone have neuroprotective effect also because of its anti-inflammatory property? The underlying mechanism needs further investigation.

Conclusion

In conclusion, the present study assessed the neuroprotective mechanism of germacrone against OGD/R-induced PC12 cells injury. These results indicated that germacrone could inhibit the autophagy effects by regulating the autophagy related proteins pathways, including PI3K III/Beclin-1/Bcl-2 and PI3K I/Akt/mTOR pathways. So, germacrone could improve viability of PC12 cells and played a neuroprotective role, which provided a certain theoretical basis for further development of germacrone.

Availability of data and materials

The analyzed data sets generated during the study are available from the corresponding author on reasonable request.

Abbreviations

Akt:

Protein kinase B

Bcl-2:

B-cell lymphoma 2

I/R:

Ischemia/reperfusion

LC3:

Light chain 3

mTOR:

The mammalian target of rapamycin

OGD/R:

Oxygen-glucose deprivation/reperfusion

PI3K I:

The class I type phosphoinositide 3-kinase

PI3K III:

The class III type phosphoinositide 3-kinase

TEM:

Transmission electron microscopy

References

  1. White E. The role for autophagy in cancer. J Clin Invest. 2015;125(1):42–6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Nat Cell Biol. 2018;20(3):233–42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–42.

    Article  PubMed  CAS  Google Scholar 

  4. Luo C, Ouyang M-W, Fang Y-Y, Li S-J, Zhou Q, Fan J, Qin Z-S, Tao T. Dexmedetomidine protects mouse brain from ischemia-reperfusion injury via inhibiting neuronal autophagy through up-regulating HIF-1α. Front Cell Neurosci. 2017;11:197.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Zhao Y, Huang G, Chen S, Gou Y, Dong Z, Zhang X. Homocysteine aggravates cortical neural cell injury through neuronal autophagy overactivation following rat cerebral ischemia-reperfusion. Int J Mol Sci. 2016;17(8):1196.

    Article  PubMed Central  CAS  Google Scholar 

  6. Zhao Y-N, Guo X-F, Li J-M, Chen C-X, Li S-X, Xu C-J. mTOR/autophagy pathway in the hippocampus of rats suffering intermittent hypoxia preconditioning and global cerebral ischemia-reperfusion. Oncotarget. 2017;8(14):23353–9.

    PubMed  PubMed Central  Google Scholar 

  7. Schaaf MB, Keulers TG, Vooijs MA. Rouschop KM.LC3/GABARAP family proteins: autophagy-(un) related functions. FASEB J. 2016;30(12):3961–78.

    Article  PubMed  CAS  Google Scholar 

  8. Frost LS, Lopes VS, Bragin A, Reyes-Reveles J, Brancato J, Cohen A, Mitchell CH, Williams DS, Boesze-Battaglia K. The contribution of melanoregulin to microtubule-associated protein 1 light chain 3 (LC3) associated phagocytosis in retinal pigment epithelium. Mol Neurobiol. 2015;52(3):1135–51.

    Article  PubMed  CAS  Google Scholar 

  9. do Nascimento-Neto LG, Cabral MG, Carneiro RF, Silva Z, Arruda FV, Nagano CS, Fernandes AR, Sampaio AH, Teixeira EH, Videira PA. Halilectin-3, a lectin from the marine sponge haliclona caerulea, induces apoptosis and autophagy in human breast cancer mcf7 cells through caspase-9 pathway and lc3-ii protein expression. Anticancer Agents Med Chem. 2018;18(4):521–8.

    Article  PubMed  CAS  Google Scholar 

  10. Song B-Q, Chi Y, Li X, Du W-J, Han Z-B, Tian J-J, Li J-J, Chen F, Wu H-H, Han L-X. Inhibition of notch signaling promotes the adipogenic differentiation of mesenchymal stem cells through autophagy activation and PTEN-PI3K/AKT/mTOR pathway. Cell Physiol Biochem. 2015;36(5):1991–2002.

    Article  PubMed  CAS  Google Scholar 

  11. Maejima Y, Kyoi S, Zhai P, Liu T, Li H, Ivessa A, Sciarretta S, Del Re DP, Zablocki DK, Hsu C-P. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013;19(11):1478–88.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Heras-Sandoval D, Pérez-Rojas JM, Hernández-Damián J, Pedraza-Chaverri J. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 2014;26(12):2694–701.

    Article  PubMed  CAS  Google Scholar 

  13. Kumar D, Shankar S, Srivastava RK. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett. 2014;343(2):179–89.

    Article  PubMed  CAS  Google Scholar 

  14. Tsai J-P, Lee C-H, Ying T-H, Lin C-L, Lin C-L, Hsueh J-T, Hsieh Y-H. Licochalcone a induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Oncotarget. 2015;6(30):28851–66.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Liu B, Gao Y-Q, Wang X-M, Wang Y-C, Fu L-Q. Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest. Mol Med Rep. 2014;10(2):1046–50.

    Article  PubMed  CAS  Google Scholar 

  16. Chen Q, Wang G, Tang L, Yu X, Li Z, Yang X. Effect of germacrone in alleviating HUVECs damaged by H2O2-induced oxidative stress. Zhongguo Zhong Yao Za Zhi. 2017;42(18):3564–71.

    PubMed  Google Scholar 

  17. Feng J, Bai X, Cui T, Zhou H, Chen Y, Xie J, Shi Q, Wang H, Zhang G. In vitro antiviral activity of germacrone against porcine reproductive and respiratory syndrome virus. Curr Microbiol. 2016;73(3):317–23.

    Article  PubMed  CAS  Google Scholar 

  18. Xie XH, Zhao H, Hu YY, Gu XD. Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells. Exp Ther Med. 2014;8(5):1611–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Kong Q, Ma Y, Yu J, Chen X. Predicted molecular targets and pathways for germacrone, curdione, and furanodiene in the treatment of breast cancer using a bioinformatics approach. Sci Rep. 2017;7(1):15543.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Ye L, Wu J, Chen W, Feng Y, Shen Z. Novel anti-cancer agents based on germacrone: design, synthesis, biological activity, docking studies and MD simulations. RSC Adv. 2017;7(7):3760–7.

    Article  CAS  Google Scholar 

  21. Lim MS, Choung SY, Jeong KW. Germacrone inhibits estrogen receptor α-mediated transcription in MCF-7 breast cancer cells. Phytother Res. 2016;30(12):2036–43.

    Article  PubMed  CAS  Google Scholar 

  22. Zhao Q, Wang Q, Wang J, Tang M, Huang S, Peng K, Han Y, Zhang J, Liu G, Fang Q, You Z. Maternal immune activation-induced PPARγ-dependent dysfunction of microglia associated with neurogenic impairment and aberrant postnatal behaviors in offspring. Neurobiol Dis. 2019;125:1–13.

    Article  PubMed  CAS  Google Scholar 

  23. Zhang L, Zhang J, You Z. Switching of the Microglial activation phenotype is a possible treatment for depression disorder. Front Cell Neurosci. 2018;12:306.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Wu T, Yin F, Kong H. Germacrone attenuates cerebral ischemia/reperfusion injury in rats via antioxidative and antiapoptotic mechanisms. J Cell Biochem. 2019;120:18901–9.

    Article  PubMed  CAS  Google Scholar 

  25. Yang G, Wang N, Seto SW, Chang D, Liang H. Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury: involvement of inhibiting autophagy via class I PI3K/Akt/mTOR signaling pathway. Brain Res Bull. 2018;140:243–57.

    Article  PubMed  CAS  Google Scholar 

  26. Van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: the MTT assay. In: Cancer cell culture: Springer; 2011. p. 237–45.

  27. Welinder C, Ekblad L. Coomassie staining as loading control in Western blot analysis. J Proteome Res. 2011;10(3):1416–9.

    Article  PubMed  CAS  Google Scholar 

  28. Masuda G, Yashiro M, Kitayama K, Miki Y, Kasashima H, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Sakurai K. Clinicopathological correlations of autophagy-related proteins LC3, Beclin 1 and p62 in gastric cancer. Anticancer Res. 2016;36(1):129–36.

    PubMed  CAS  Google Scholar 

  29. Kang Y, Liu J, Wu J, Yin Q, Liang H, Chen A, Shao L. Graphene oxide and reduced graphene oxide induced neural pheochromocytoma-derived PC12 cell lines apoptosis and cell cycle alterations via the ERK signaling pathways. Int J Nanomed. 2017;12:5501–10.

    Article  CAS  Google Scholar 

  30. Greene LA. NGF-responsive clonal PC12 pheochromocytoma cells as tools for neuropharmacologic investigations. In: Chemotherapy: Proceedings of the 7th International Congress of Pharmacology, vol.10. Paris: Elsevier;1978; 2016. p. 197.

    Google Scholar 

  31. Liu Y, Levine B. Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ. 2015;22(3):367–76.

    Article  PubMed  CAS  Google Scholar 

  32. Wang M, Li Y-J, Ding Y, Zhang H-N, Sun T, Zhang K, Yang L, Guo Y-Y, Liu S-B, Zhao M-G. Silibinin prevents autophagic cell death upon oxidative stress in cortical neurons and cerebral ischemia-reperfusion injury. Mol Neurobiol. 2016;53(2):932–43.

    Article  PubMed  CAS  Google Scholar 

  33. Lin S-P, Ye S, Long Y, Fan Y, Mao H-F, Chen M-T, Ma Q-J. Circular RNA expression alterations are involved in OGD/R-induced neuron injury. Biochem Biophys Res Commun. 2016;471(1):52–6.

    Article  PubMed  CAS  Google Scholar 

  34. Hu Z, Yang B, Mo X, Zhou F. HspB8 mediates neuroprotection against OGD/R in N2A cells through the phosphoinositide 3-kinase/Akt pathway. Brain Res. 2016;1644:15–21.

    Article  PubMed  CAS  Google Scholar 

  35. Gaucher S, Jarraya M. Comparison of the PrestoBlue and LDH release assays with the MTT assay for skin viability assessment. Cell Tissue Bank. 2015;16(3):325–9.

    Article  PubMed  CAS  Google Scholar 

  36. Lazari MM, Orhon I, Codogno P, Dupont N. Monitoring of autophagy and cell volume regulation in kidney epithelial cells in response to fluid shear stress. In: Autophagy: Springer; 2019. p. 331–40.

    Google Scholar 

  37. Z-t M, W-n L, Y-r Z, Gong Q-H. Icariin attenuates OGD/R-induced autophagy via Bcl-2-dependent cross talk between apoptosis and autophagy in PC12 cells. Evid Based Complement Alternat Med. 2016:4343084.

  38. Li T-T, Zhu D, Mou T, Guo Z, Pu J-L, Chen Q-S, Wei X-F, Wu Z-J. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway. Mol Immunol. 2017;87:132–40.

    Article  PubMed  CAS  Google Scholar 

  39. Jian J, Xuan F, Qin F, Huang R. Bauhinia championii flavone inhibits apoptosis and autophagy via the PI3K/Akt pathway in myocardial ischemia/reperfusion injury in rats. Drug Des Devel Ther. 2015;9:5933–45.

    PubMed  PubMed Central  CAS  Google Scholar 

  40. Liu Y, Wang W, Fang B, Ma F, Zheng Q, Deng P, Zhao S, Chen M, Yang G, He G. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2013;698(1–3):95–102.

    Article  PubMed  CAS  Google Scholar 

  41. Liao Q, Qian Z, Liu R, An L, Chen X. Germacrone inhibits early stages of influenza virus infection. Antiviral Res. 2013;100(3):578–88.

    Article  PubMed  CAS  Google Scholar 

  42. Liu Y-Y, Zheng Q, Fang B, Wang W, Ma F-Y, Roshan S, Banafa A, Chen M-J, Chang J-L, Deng X-M. Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2/STAT3 signalling pathway. J Huazhong Univ Sci Technolog Med Sci. 2013;33(3):339–45.

    Article  PubMed  CAS  Google Scholar 

  43. Guo M-L, Liao K, Periyasamy P, Yang L, Cai Y, Callen SE, Buch S. Cocaine-mediated microglial activation involves the ER stress-autophagy axis. Autophagy. 2015;11(7):995–1009.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Chang Y, Kong R. Ganoderic acid a alleviates hypoxia-induced apoptosis, autophagy, and inflammation in rat neural stem cells through the PI3K/AKT/mTOR pathways. Phytother Res. 2019;33:1448–56.

    Article  PubMed  CAS  Google Scholar 

  45. Huang X-P, Ding H, Yang X-Q, Li J-X, Tang B, Liu X-D, Tang Y-H, Deng C-Q. Synergism and mechanism of Astragaloside IV combined with Ginsenoside Rg1 against autophagic injury of PC12 cells induced by oxygen glucose deprivation/reoxygenation. Biomed Pharmacother. 2017;89:124–34.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Not applicable

Funding

We thank the financial support from 2017 Annual Plan of Key Topics for Medical Science Research in Hebei Province (20171375) for the data collection.

Author information

Authors and Affiliations

  1. Department of Second Neurology, Tangshan Gongren Hospital, No.27 Wenhua Road, Tangshan City, Hebei Province, 063000, People’s Republic of China

    Jianxing Zhang, Li Yuan, Sujie Wang, Huiqin Bi, Guojuan Chen, Jingjing Li & Lili Chen

  2. Department of One Anesthesiology, Tangshan Gongren Hospital, Tangshan City, Hebei Province, 063000, People’s Republic of China

    Jiang Liu

Authors
  1. Jianxing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sujie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huiqin Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guojuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jingjing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lili Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JXZ, LY, LLC designed the study, performed and analyzed data, prepared manuscript. SJW, JL, HQB, GJC, JJL performed and analyzed data, prepared manuscript. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Lili Chen.

Ethics declarations

Ethics approval and consent to participate

The present study was approved by the Ethics Committee of Tangshan Gongren Hospital.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Yuan, L., Wang, S. et al. Germacrone protects against oxygen-glucose deprivation/reperfusion injury by inhibiting autophagy processes in PC12 cells. BMC Complement Med Ther 20, 77 (2020). https://doi.org/10.1186/s12906-020-2865-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-020-2865-1

Keywords

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us